The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...
A first-of-its-kind study has found that women who discontinued GLP-1 medications upon becoming pregnant experienced ...
The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.
The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...
Jaime Bautch and Mykala Lopez from Bellissimo Aesthetics join us on The Morning Blend to discuss treatments that pair with ...
While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...
The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it ...
Panelists discuss how patients can maintain nutrition during talquetamab treatment by focusing on texture and food presentation when taste is impaired, using high-calorie options, and remembering that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback